Literature DB >> 33772103

Extracellular vesicles are associated with C-reactive protein in sepsis.

Birgit Fendl1, René Weiss1, Tanja Eichhorn1, Ingrid Linsberger1, Taras Afonyushkin2, Florian Puhm2, Christoph J Binder2, Michael B Fischer3, Viktoria Weber4.   

Abstract

There is increasing evidence that C-reactive protein (CRP) can mediate inflammatory reactions following the transformation of functionally inert pentameric CRP (pCRP) into its structural isoform pCRP* and into monomeric CRP (mCRP). This conversion can occur on the membranes of apoptotic or activated cells or on extracellular vesicles (EVs) shed from the cell surface. Here, we characterized the association of CRP with EVs in plasma from sepsis patients using flow cytometry, and found highly elevated levels of total EV counts and CRP+ EVs as compared to healthy individuals. We further assessed the ability of PentraSorb CRP, an extracorporeal device for the adsorption of CRP, to deplete free CRP and CRP+ EVs. Treatment of septic plasma with the adsorbent in vitro resulted in almost complete removal of both, free CRP and CRP+ EVs, while total EV counts remained largely unaffected, indicating the detachment of CRP from the EV surface. EVs from septic plasma elicited a release of interleukin-8 from cultured human monocytes, which was significantly reduced by adsorbent treatment prior to EV isolation. Our findings provide evidence that CRP+ EVs exhibit pro-inflammatory characteristics and can contribute to the spreading of inflammation throughout the circulation on top of their pro-coagulant activity.

Entities:  

Year:  2021        PMID: 33772103      PMCID: PMC7997920          DOI: 10.1038/s41598-021-86489-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  52 in total

1.  PentraSorb C-Reactive Protein: Characterization of the Selective C-Reactive Protein Adsorber Resin.

Authors:  Stephan Mattecka; Patrizia Brunner; Britta Hähnel; Rudolf Kunze; Birgit Vogt; Ahmed Sheriff
Journal:  Ther Apher Dial       Date:  2019-03-21       Impact factor: 1.762

2.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.

Authors:  Joakim Huber; Anja Vales; Goran Mitulovic; Michael Blumer; Rainer Schmid; Joseph L Witztum; Bernd R Binder; Norbert Leitinger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

4.  Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease.

Authors:  Jeffrey R Crawford; JoAnn Trial; Vijay Nambi; Ron C Hoogeveen; George E Taffet; Mark L Entman
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

5.  C-reactive protein augments interleukin-8 secretion in human peripheral blood monocytes.

Authors:  Liangqi Xie; Lina Chang; Youfei Guan; Xian Wang
Journal:  J Cardiovasc Pharmacol       Date:  2005-11       Impact factor: 3.105

6.  Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.

Authors:  I C van Eijk; M E Tushuizen; A Sturk; B A C Dijkmans; M Boers; A E Voskuyl; M Diamant; G J Wolbink; R Nieuwland; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-11-16       Impact factor: 19.103

7.  Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous.

Authors:  Ratnadeep Mukherjee; Pijus Kanti Barman; Pravat Kumar Thatoi; Rina Tripathy; Bidyut Kumar Das; Balachandran Ravindran
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

8.  Extracellular Vesicles Derived From Platelets, Red Blood Cells, and Monocyte-Like Cells Differ Regarding Their Ability to Induce Factor XII-Dependent Thrombin Generation.

Authors:  Carla Tripisciano; René Weiss; Sobha Karuthedom George; Michael B Fischer; Viktoria Weber
Journal:  Front Cell Dev Biol       Date:  2020-05-05

9.  Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae.

Authors:  Tanja Buchacher; Herbert Wiesinger-Mayr; Klemens Vierlinger; Beate M Rüger; Gerold Stanek; Michael B Fischer; Viktoria Weber
Journal:  BMC Immunol       Date:  2014-12-09       Impact factor: 3.615

10.  C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty.

Authors:  Christian Stumpf; Ahmed Sheriff; Stefan Zimmermann; Liane Schaefauer; Christian Schlundt; Dorette Raaz; Christoph D Garlichs; Stephan Achenbach
Journal:  Arch Med Sci       Date:  2017-08-03       Impact factor: 3.318

View more
  7 in total

Review 1.  Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis.

Authors:  Marie Ebeyer-Masotta; Tanja Eichhorn; René Weiss; Lucia Lauková; Viktoria Weber
Journal:  Front Cell Dev Biol       Date:  2022-07-06

Review 2.  Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.

Authors:  Carlos A Labarrere; Ghassan S Kassab
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

3.  The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics.

Authors:  Leon G Coleman
Journal:  Neural Regen Res       Date:  2022-05       Impact factor: 5.135

Review 4.  Monomeric C-Reactive Protein: Current Perspectives for Utilization and Inclusion as a Prognostic Indicator and Therapeutic Target.

Authors:  Mark Slevin; Nima Heidari; Leonard Azamfirei
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

5.  Repetitive Treatment with Volatile Anesthetics Does Not Affect the In Vivo Plasma Concentration and Composition of Extracellular Vesicles in Rats.

Authors:  Christian Bleilevens; Christian Beckers; Alexander Theissen; Tamara Fechter; Eva Miriam Buhl; Johannes Greven; Sandra Kraemer; Sebastian Wendt
Journal:  Curr Issues Mol Biol       Date:  2021-11-13       Impact factor: 2.976

Review 6.  Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome.

Authors:  Wenqiang Jing; Huijuan Wang; Liying Zhan; Wei Yan
Journal:  Front Cell Infect Microbiol       Date:  2022-04-07       Impact factor: 6.073

Review 7.  The roles of extracellular vesicles in the immune system.

Authors:  Edit I Buzas
Journal:  Nat Rev Immunol       Date:  2022-08-04       Impact factor: 108.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.